SOAT1 and COVID-19: JAK/STAT is a signaling pathway for multiple inflammatory cytokines in COVID‐19, and its properties in inflammation and immune regulation can be used to manage CS, as many studies have used JAK/STAT signaling inhibition as an intervention therapy for targeting COVID‐19 (reviewed in Refs.